CN111973470A - Functional shaping eye cream - Google Patents
Functional shaping eye cream Download PDFInfo
- Publication number
- CN111973470A CN111973470A CN202010686364.5A CN202010686364A CN111973470A CN 111973470 A CN111973470 A CN 111973470A CN 202010686364 A CN202010686364 A CN 202010686364A CN 111973470 A CN111973470 A CN 111973470A
- Authority
- CN
- China
- Prior art keywords
- weight
- parts
- eye cream
- powder
- alcohol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006071 cream Substances 0.000 title claims abstract description 58
- 238000007493 shaping process Methods 0.000 title claims abstract description 23
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 50
- 239000000843 powder Substances 0.000 claims abstract description 46
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims abstract description 34
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims abstract description 30
- 102000008186 Collagen Human genes 0.000 claims abstract description 23
- 108010035532 Collagen Proteins 0.000 claims abstract description 23
- 229920001436 collagen Polymers 0.000 claims abstract description 23
- 241000195619 Euglena gracilis Species 0.000 claims abstract description 20
- 150000004676 glycans Chemical class 0.000 claims abstract description 20
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 20
- 239000005017 polysaccharide Substances 0.000 claims abstract description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 20
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 17
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims abstract description 17
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 17
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 17
- 229940032094 squalane Drugs 0.000 claims abstract description 17
- 241001116389 Aloe Species 0.000 claims abstract description 16
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims abstract description 16
- 241001135917 Vitellaria paradoxa Species 0.000 claims abstract description 16
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 16
- 229940057910 shea butter Drugs 0.000 claims abstract description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 15
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims abstract description 15
- 229930194248 Licoflavone Natural products 0.000 claims abstract description 15
- MEHHCBRCXIDGKZ-UHFFFAOYSA-N Licoflavone C Natural products CC(C)=CCC1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 MEHHCBRCXIDGKZ-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 15
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000004205 dimethyl polysiloxane Substances 0.000 claims abstract description 15
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 claims abstract description 15
- 229940119170 jojoba wax Drugs 0.000 claims abstract description 15
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims abstract description 15
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims abstract description 15
- 229960002216 methylparaben Drugs 0.000 claims abstract description 15
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims abstract description 15
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims abstract description 15
- 229920002401 polyacrylamide Polymers 0.000 claims abstract description 15
- -1 polydimethylsiloxane Polymers 0.000 claims abstract description 15
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 15
- 229920001285 xanthan gum Polymers 0.000 claims abstract description 15
- 239000000230 xanthan gum Substances 0.000 claims abstract description 15
- 229940082509 xanthan gum Drugs 0.000 claims abstract description 15
- 235000010493 xanthan gum Nutrition 0.000 claims abstract description 15
- 229940082500 cetostearyl alcohol Drugs 0.000 claims abstract description 11
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 claims abstract description 11
- 240000000950 Hippophae rhamnoides Species 0.000 claims abstract 3
- 239000003963 antioxidant agent Substances 0.000 claims description 15
- 230000003078 antioxidant effect Effects 0.000 claims description 15
- 235000006708 antioxidants Nutrition 0.000 claims description 15
- 239000002537 cosmetic Substances 0.000 claims description 9
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims description 7
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims description 7
- 229940106189 ceramide Drugs 0.000 claims description 7
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 4
- 229940081733 cetearyl alcohol Drugs 0.000 claims description 4
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 2
- FENRSEGZMITUEF-ATTCVCFYSA-E [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].OP(=O)([O-])O[C@@H]1[C@@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H]1OP(=O)([O-])[O-] Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].OP(=O)([O-])O[C@@H]1[C@@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H]1OP(=O)([O-])[O-] FENRSEGZMITUEF-ATTCVCFYSA-E 0.000 claims description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 claims description 2
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims description 2
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 2
- 229940083982 sodium phytate Drugs 0.000 claims description 2
- 229940042585 tocopherol acetate Drugs 0.000 claims description 2
- 235000011187 glycerol Nutrition 0.000 claims 3
- 210000003491 skin Anatomy 0.000 description 23
- 230000003712 anti-aging effect Effects 0.000 description 22
- 239000002994 raw material Substances 0.000 description 20
- 230000032683 aging Effects 0.000 description 15
- 241000229143 Hippophae Species 0.000 description 12
- 239000003814 drug Substances 0.000 description 10
- 238000001035 drying Methods 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 238000007873 sieving Methods 0.000 description 5
- 230000009759 skin aging Effects 0.000 description 5
- 230000001954 sterilising effect Effects 0.000 description 5
- 238000005303 weighing Methods 0.000 description 5
- 230000037303 wrinkles Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000009471 action Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000008433 psychological processes and functions Effects 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 206010051246 Photodermatosis Diseases 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000005786 degenerative changes Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000007368 endocrine function Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
Abstract
The invention relates to functional shaping eye cream which comprises the following components in parts by weight: 0.2-3 parts of sea-buckthorn powder; 2-50 parts of melissa leaf extract and 1.8-2.2 parts of cetostearyl alcohol; 2.5-3.5 parts by weight of squalane; 0.1-0.11 weight part of aloe gel powder; 1-10 parts of shea butter; 1-3 parts of hydrogenated jojoba oil; 0.1-0.2 parts by weight of methylparaben; 0.01-0.04 parts by weight of sodium hyaluronate; 0.1-0.14 parts by weight of xanthan gum; 1-4 parts by weight of glycerol; 1-7 parts of polyethylene glycol; 0.3-0.6 part by weight of polyacrylamide/C13-14 isoparaffin/laureth alcohol; 0.2-0.6 part by weight of polydimethylsiloxane/dimethiconol; 0.02-0.08 parts by weight of licoflavone; 1-2 parts by weight of butanediol; 1-4 parts by weight of euglena gracilis polysaccharide/hydrolyzed collagen; the balance being water.
Description
Technical Field
The invention relates to the technical field of cosmetics, in particular to functional shaping eye cream.
Background
Aging refers to the phenomenon that the physiological and psychological adaptive capacity of the body to the environment is gradually reduced and gradually dies. Aging can be divided into two categories: physiological aging and pathological aging. The former refers to a physiological degenerative process occurring after maturation and the latter is an aging change due to various external factors including various diseases. The two are practically indistinguishable. In summary, aging is a necessary result of the combined action of many pathological, physiological and psychological processes, and is a biological psychological process in the final stage of growth and development of individuals, and it is becoming more and more important how to delay aging and reduce the influence of the environment on the skin of the human body, thereby improving the aging state of the skin.
The skin is used as the first barrier of human body, so that the skin is aged and aged all the time, the metabolism of cells is dead, collagen is lost, the elasticity of the collagen is slowly reduced, the collagen becomes thinner, weaker and loose, and the most direct impression is that wrinkles are long, and the like. Skin aging is generally natural aging and photoaging. The former mainly refers to aging caused by non-resistant factors existing in the body such as heredity, gravity, endocrine and immune functions with the aging; the latter is mainly due to the action of ultraviolet rays, which accelerates the process of natural aging, and a series of environmental exposures such as climate change, environmental pollution and the like also have direct influence on the aging of skin. How to find anti-aging by understanding the factors of skin aging and the state of skin aging become a research topic, wherein the anti-aging approaches mainly comprise: protecting the skin from external environmental stimuli; eliminating redundant free radicals in cells; repairing skin cells and supplementing nutrition. Skin aging is the prevention of gradual functional and organic degenerative changes in the skin over time, manifested by the prevention of wrinkles, dryness, scaling, sagging and discolorations. The aging of human body is firstly expressed on the skin layer and is the growth of eyes, especially the eye veins. The anti-aging cosmetic is a cosmetic for realizing anti-aging effect, is one of important effect type cosmetics, and the anti-aging cosmetic is an eager demand in the market under the basic condition of improving eyes, namely a skin care product for shaping eye cream.
Disclosure of Invention
Therefore, the invention provides functional shaping eye cream which is used for overcoming the problems that fine lines are easy to grow on eyes of a human body and the eyes of the human body are easy to age in the prior art.
The invention provides functional shaping eye cream which comprises the following components in parts by weight:
0.2-3 parts of sea-buckthorn powder; 2-50 parts of melissa leaf extract and 1.8-2.2 parts of cetostearyl alcohol; 2.5-3.5 parts by weight of squalane; 0.1-0.11 weight part of aloe gel powder; 1-10 parts of shea butter; 1-3 parts of hydrogenated jojoba oil; 0.1-0.2 parts by weight of methylparaben; 0.01-0.04 parts by weight of sodium hyaluronate; 0.1-0.14 parts by weight of xanthan gum; 1-4 parts by weight of glycerol; 1-7 parts of polyethylene glycol; 0.3-0.6 part by weight of polyacrylamide/C13-14 isoparaffin/laureth alcohol; 0.2-0.6 part by weight of polydimethylsiloxane/dimethiconol; 0.02-0.08 parts by weight of licoflavone; 1-2 parts by weight of butanediol; 1-4 parts by weight of euglena gracilis polysaccharide/hydrolyzed collagen; the balance being water.
Further, the eye cream contains 3 parts by weight of sea buckthorn powder; 50 parts by weight of melissa leaf extract, 2.2 parts by weight of cetearyl alcohol; 3.5 parts by weight of squalane; 0.11 part by weight of aloe gel powder; 10 parts of shea butter; 3 parts by weight of hydrogenated jojoba oil; 0.2 part by weight of methylparaben; 0.04 part by weight of sodium hyaluronate; 0.14 part by weight of xanthan gum; 4 parts of glycerol; 7 parts of polyethylene glycol; 0.6 part by weight of polyacrylamide/C13-14 isoparaffin/laureth alcohol; 0.6 part by weight of polydimethylsiloxane/dimethiconol; 0.08 part of licoflavone; 2 parts of butanediol; 4 parts by weight of euglena gracilis polysaccharide/hydrolyzed collagen; the balance being water.
Further, the eye cream also comprises 1-30 parts of ceramide.
Further, the eye cream also comprises 10-44 parts of antioxidant.
Further, the sodium hyaluronate can be replaced by glycerol or 1, 3-butanediol, 1, 2-pentanediol.
Further, the antioxidant is oil-soluble vitamin E acetate, sodium phytate, or a mixture thereof.
Further, the eye cream is applied to the preparation of cosmetics.
Further, the cosmetic is eye cream.
Compared with the prior art, the functional shaping eye cream has the beneficial effects that the squalane adopted by the functional shaping eye cream provided by the invention is selected and proportioned, so that the improvement effect of the squalane on the eye skin of a human body is improved, and the functional shaping eye cream has an obvious anti-aging effect.
Furthermore, in the use process of the functional shaping eye cream, due to the adoption of the aloe gel powder, the eye skin is mild, the skin is not allergic or infected, the use of the shea butter can promote the skin to be moisturized and not dry, improve the moisture content of the skin, promote the metabolism of the skin, supplement amino acid lost from the eye skin in the use process of an antioxidant, effectively inhibit and remove free radicals, relieve skin aging, promote the alternation of new and old cells, improve the skin smoothness, increase the skin elasticity, fade fine lines of the eye skin and delay the growth time of the fine lines.
Detailed Description
In order that the objects and advantages of the invention will be more clearly understood, the invention is further described below with reference to examples; it should be understood that the specific embodiments described herein are merely illustrative of the invention and are not intended to limit the invention.
Example 1
The invention provides functional shaping eye cream which adopts the following raw material components in percentage by weight: the eye cream contains 3 parts by weight of sea buckthorn powder; 50 parts by weight of melissa leaf extract, 2.2 parts by weight of cetearyl alcohol; 3.5 parts by weight of squalane; aloe gel powder 0.11 weight portions; 10 parts of shea butter; 3 parts by weight of hydrogenated jojoba oil; 0.2 part by weight of methylparaben; 0.04 part by weight of sodium hyaluronate; 0.14 part by weight of xanthan gum; 4 parts of glycerol; 7 parts of polyethylene glycol; 0.6 part by weight of polyacrylamide/C13-14 isoparaffin/laureth alcohol; 0.6 part by weight of polydimethylsiloxane/dimethiconol; 0.08 part of licoflavone; 2 parts of butanediol; 4 parts by weight of euglena gracilis polysaccharide/hydrolyzed collagen; the balance being water.
The preparation method of the functional shaping eye cream comprises the following steps:
step 1: weighing 3 parts by weight of sea buckthorn powder according to a proportion; 50 parts by weight of melissa leaf extract, 2.2 parts by weight of cetearyl alcohol; 3.5 parts by weight of squalane; 0.11 part by weight of aloe gel powder; 10 parts of shea butter; 3 parts by weight of hydrogenated jojoba oil; 0.2 part by weight of methylparaben and 0.04 part by weight of sodium hyaluronate; 0.14 part by weight of xanthan gum; 4 parts of glycerol; 7 parts of polyethylene glycol; 0.6 part by weight of polyacrylamide/C13-14 isoparaffin/laureth alcohol; 0.6 part by weight of polydimethylsiloxane/dimethiconol; 0.08 part of licoflavone; 2 parts of butanediol; 4 parts by weight of euglena gracilis polysaccharide/hydrolyzed collagen, and taking the euglena gracilis polysaccharide/hydrolyzed collagen as a raw material;
step 2: drying and crushing the raw materials in the step 1 into fine powder, sieving the fine powder, and sterilizing the fine powder by using an ultraviolet lamp;
and step 3: uniformly mixing the raw materials in the step 2, adding the ceramide content, adding the mixture into water, adding water, decocting for 2 hours, extracting, filtering out liquid medicine, and removing medicine residues;
and 4, step 4: the antioxidant is slowly added to the solution obtained in step 3 and continuously stirred until the antioxidant is fully dissolved.
Example 2
The invention provides functional shaping eye cream which adopts the following raw material components in percentage by weight: the eye cream contains 0.2 weight part of seabuckthorn powder; 2 parts of melissa leaf extract and 1.8 parts of cetostearyl alcohol; 2.5 parts by weight of squalane; 0.1 part by weight of aloe gel powder; 1 part of shea butter; 1 part by weight of hydrogenated jojoba oil; 0.1 part by weight of methylparaben; 0.01 part by weight of sodium hyaluronate; 0.1 part by weight of xanthan gum; 1 part by weight of glycerol; 1 part by weight of polyethylene glycol; 0.3 part by weight of polyacrylamide/C13-14 isoparaffin/laureth alcohol; 0.2 part by weight of polydimethylsiloxane/dimethiconol; 0.02 part by weight of licoflavone; 1 part by weight of butanediol; 1 part by weight of euglena gracilis polysaccharide/hydrolyzed collagen; the balance being water.
The preparation method of the functional shaping eye cream comprises the following steps:
step 1: weighing 0.2 part of sea buckthorn powder in proportion; 2 parts of melissa leaf extract and 1.8 parts of cetostearyl alcohol; 2.5 parts by weight of squalane; 0.1 part by weight of aloe gel powder; 1 part of shea butter; 1 part by weight of hydrogenated jojoba oil; 0.1 part by weight of methylparaben; 0.01 part by weight of sodium hyaluronate; 0.1 part by weight of xanthan gum; 1 part by weight of glycerol; 1 part by weight of polyethylene glycol; 0.3 part by weight of polyacrylamide/C13-14 isoparaffin/laureth alcohol; 0.2 part by weight of polydimethylsiloxane/dimethiconol; 0.02 part by weight of licoflavone; 1 part by weight of butanediol; 1 part by weight of euglena gracilis polysaccharide/hydrolyzed collagen, and taking the euglena gracilis polysaccharide/hydrolyzed collagen as a raw material;
step 2: drying and crushing the raw materials in the step 1 into fine powder, sieving the fine powder, and sterilizing the fine powder by using an ultraviolet lamp;
and step 3: uniformly mixing the raw materials in the step 2, adding the ceramide content, adding the mixture into water, adding water, decocting for 2 hours, extracting, filtering out liquid medicine, and removing medicine residues;
and 4, step 4: the antioxidant is slowly added to the solution obtained in step 3 and continuously stirred until the antioxidant is fully dissolved.
Example 3
The invention provides functional shaping eye cream which adopts the following raw material components in percentage by weight: the eye cream contains 1 part by weight of seabuckthorn powder; 5 parts of melissa leaf extract and 2 parts of cetostearyl alcohol; 3 parts of squalane; 0.1 part by weight of aloe gel powder; 5 parts of shea butter; 2 parts by weight of hydrogenated jojoba oil; 0.15 part by weight of methylparaben; 0.03 part by weight of sodium hyaluronate; 0.11 part by weight of xanthan gum; 2 parts by weight of glycerol; 5 parts of polyethylene glycol; 0.5 part by weight of polyacrylamide/C13-14 isoparaffin/laureth alcohol; 0.5 part by weight of polydimethylsiloxane/dimethiconol; 0.05 part by weight of licoflavone; 1.5 parts by weight of butanediol; 1.5 parts by weight of euglena gracilis polysaccharide/hydrolyzed collagen; the balance being water.
The preparation method of the functional shaping eye cream comprises the following steps:
step 1: weighing 1 part by weight of sea buckthorn powder according to a proportion; 5 parts of melissa leaf extract and 2 parts of cetostearyl alcohol; 3 parts of squalane; 0.1 part by weight of aloe gel powder; 5 parts of shea butter; 2 parts by weight of hydrogenated jojoba oil; 0.15 part by weight of methylparaben; 0.03 part by weight of sodium hyaluronate; 0.11 part by weight of xanthan gum; 2 parts by weight of glycerol; 5 parts of polyethylene glycol; 0.5 part by weight of polyacrylamide/C13-14 isoparaffin/laureth alcohol; 0.5 part by weight of polydimethylsiloxane/dimethiconol; 0.05 part by weight of licoflavone; 1.5 parts by weight of butanediol; 1.5 parts by weight of euglena gracilis polysaccharide/hydrolyzed collagen, and using the euglena gracilis polysaccharide/hydrolyzed collagen as a raw material;
step 2: drying and crushing the raw materials in the step 1 into fine powder, sieving the fine powder, and sterilizing the fine powder by using an ultraviolet lamp;
and step 3: uniformly mixing the raw materials in the step 2, adding the ceramide content, adding the mixture into water, adding water, decocting for 2 hours, extracting, filtering out liquid medicine, and removing medicine residues;
and 4, step 4: the antioxidant is slowly added to the solution obtained in step 3 and continuously stirred until the antioxidant is fully dissolved.
Example 4
The invention provides functional shaping eye cream which adopts the following raw material components in percentage by weight: the eye cream contains 0.8 weight part of sea buckthorn powder; 30 parts of melissa leaf extract and 1.9 parts of cetostearyl alcohol; 2.9 parts of squalane; 0.108 weight part of aloe gel powder; 8 parts of shea butter; 1.5 parts by weight of hydrogenated jojoba oil; 0.14 part by weight of methylparaben; 0.03 part by weight of sodium hyaluronate; 0.13 part by weight of xanthan gum; 3 parts of glycerol; 5 parts of polyethylene glycol; 0.4 part by weight of polyacrylamide/C13-14 isoparaffin/laureth alcohol; 0.5 part by weight of polydimethylsiloxane/dimethiconol; 0.05 part by weight of licoflavone; 1.4 parts by weight of butanediol; 2 parts by weight of euglena gracilis polysaccharide/hydrolyzed collagen; the balance being water.
The preparation method of the functional shaping eye cream comprises the following steps:
step 1: weighing 0.8 part of sea buckthorn powder in proportion; 30 parts of melissa leaf extract and 1.9 parts of cetostearyl alcohol; 2.9 parts of squalane; 0.108 weight part of aloe gel powder; 8 parts of shea butter; 1.5 parts by weight of hydrogenated jojoba oil; 0.14 part by weight of methylparaben; 0.03 part by weight of sodium hyaluronate; 0.13 part by weight of xanthan gum; 3 parts of glycerol; 5 parts of polyethylene glycol; 0.4 part by weight of polyacrylamide/C13-14 isoparaffin/laureth alcohol; 0.5 part by weight of polydimethylsiloxane/dimethiconol; 0.05 part by weight of licoflavone; 1.4 parts by weight of butanediol; 2 parts by weight of euglena gracilis polysaccharide/hydrolyzed collagen, and taking the euglena gracilis polysaccharide/hydrolyzed collagen as a raw material;
step 2: drying and crushing the raw materials in the step 1 into fine powder, sieving the fine powder, and sterilizing the fine powder by using an ultraviolet lamp;
and step 3: uniformly mixing the raw materials in the step 2, adding the ceramide content, adding the mixture into water, adding water, decocting for 2 hours, extracting, filtering out liquid medicine, and removing medicine residues;
and 4, step 4: the antioxidant is slowly added to the solution obtained in step 3 and continuously stirred until the antioxidant is fully dissolved.
Example 5
The invention provides functional shaping eye cream which adopts the following raw material components in percentage by weight: the eye cream contains 0.8 weight part of sea buckthorn powder; 33 parts of melissa leaf extract and 2 parts of cetostearyl alcohol; 2.99 parts by weight of squalane; aloe gel powder 0.109 weight portions; 8 parts of shea butter; 2.7 parts by weight of hydrogenated jojoba oil; 0.15 part by weight of methylparaben; 0.019 parts by weight of sodium hyaluronate; 0.13 part by weight of xanthan gum; 1.5 parts by weight of glycerol; 1 part by weight of polyethylene glycol; 0.3 part by weight of polyacrylamide/C13-14 isoparaffin/laureth alcohol; 0.2 part by weight of polydimethylsiloxane/dimethiconol; 0.02 part by weight of licoflavone; 1 part by weight of butanediol; 1 part by weight of euglena gracilis polysaccharide/hydrolyzed collagen; the balance being water.
The preparation method of the functional shaping eye cream comprises the following steps:
step 1: weighing 0.8 part of sea buckthorn powder in proportion; 33 parts of melissa leaf extract and 2 parts of cetostearyl alcohol; 2.99 parts by weight of squalane; 0.109 weight portion of aloe gel powder; 8 parts of shea butter; 2.7 parts by weight of hydrogenated jojoba oil; 0.15 part by weight of methylparaben; 0.019 parts by weight of sodium hyaluronate; 0.13 part by weight of xanthan gum; 1.5 parts by weight of glycerol; 1 part by weight of polyethylene glycol; 0.3 part by weight of polyacrylamide/C13-14 isoparaffin/laureth alcohol; 0.2 part by weight of polydimethylsiloxane/dimethiconol; 0.02 part by weight of licoflavone; 1 part by weight of butanediol; 1 part by weight of euglena gracilis polysaccharide/hydrolyzed collagen, and taking the euglena gracilis polysaccharide/hydrolyzed collagen as a raw material;
step 2: drying and crushing the raw materials in the step 1 into fine powder, sieving the fine powder, and sterilizing the fine powder by using an ultraviolet lamp;
and step 3: uniformly mixing the raw materials in the step 2, adding the ceramide content, adding the mixture into water, adding water, decocting for 2 hours, extracting, filtering out liquid medicine, and removing medicine residues;
and 4, step 4: the antioxidant is slowly added to the solution obtained in step 3 and continuously stirred until the antioxidant is fully dissolved.
In the combination of examples and subjects, examples 1 to 5 were applied to the subjects, respectively, by using the eye cream after cleansing the face every morning and evening for two months, and the following data were obtained:
subject 1: after the eye cream disclosed by the invention is used for two months, the anti-aging efficiency reaches 70%, and the color of the skin of the eyes is uniform; after two months of using the eye cream of the embodiment 2, the anti-aging efficacy efficiency reaches 80%; after two months of using the eye cream of the embodiment 3, the anti-aging efficacy efficiency reaches 50%; after two months of using the eye cream of the embodiment 4, the anti-aging efficacy efficiency reaches 68 percent; after two months of using the eye cream of the embodiment 5, the anti-aging efficacy efficiency reaches 82%;
subject 2: after the age of 35 years, wrinkles and dull skin exist on eyes, the anti-aging efficacy efficiency reaches 66% and the color of the skin of the eyes is uniform after two months of using the eye cream of the embodiment 1; after two months of using the eye cream of the embodiment 2, the anti-aging efficacy efficiency reaches 78%; after two months of using the eye cream of the embodiment 3, the anti-aging efficacy efficiency reaches 45 percent; after two months of using the eye cream of the embodiment 4, the anti-aging efficacy efficiency reaches 65%; after two months of using the eye cream of example 5, the anti-aging efficacy efficiency reached 78%;
subject 3: after the age of 55 years, the eyes have many wrinkles and dull skin, and after the eye cream of the embodiment 1 is used, the anti-aging efficiency reaches 50 percent, the eye skin moisturizing effect is good, and fine lines are faded; after two months of using the eye cream of the embodiment 2, the anti-aging efficacy efficiency reaches 68 percent; after two months of using the eye cream of the embodiment 3, the anti-aging efficacy efficiency reaches 40%; after two months of using the eye cream of the embodiment 4, the anti-aging efficacy efficiency reaches 60 percent; after two months of using the eye cream of the embodiment 5, the anti-aging efficacy efficiency reaches 70%;
the implementation shows that the eye cream has good oxidation resistance, is fresh and non-greasy, easily solves the problems of dark under-eye circles, under-eye pouches, eye wrinkles, looseness and the like, has a vivid stereo eye shape, has strong capacity of eliminating free radicals, and also shows that the eye cream has good anti-aging performance; improving the activity of eye cells and delaying the appearance aging; enhancing the human body pressure resistance and relieving fatigue.
So far, the technical solutions of the present invention have been described in connection with the preferred embodiments, but it is easily understood by those skilled in the art that the scope of the present invention is obviously not limited to these specific embodiments. Equivalent changes or substitutions of related technical features can be made by those skilled in the art without departing from the principle of the invention, and the technical scheme after the changes or substitutions can fall into the protection scope of the invention.
Claims (8)
1. A functional shaping eye cream is characterized by comprising the following components in parts by weight:
0.2-3 parts of sea-buckthorn powder; 2-50 parts of melissa leaf extract and 1.8-2.2 parts of cetostearyl alcohol; 2.5-3.5 parts by weight of squalane; 0.1-0.11 weight part of aloe gel powder; 1-10 parts of shea butter; 1-3 parts of hydrogenated jojoba oil; 0.1-0.2 parts by weight of methylparaben; 0.01-0.04 parts by weight of sodium hyaluronate; 0.1-0.14 parts by weight of xanthan gum; 1-4 parts by weight of glycerol; 1-7 parts of polyethylene glycol; 0.3-0.6 part by weight of polyacrylamide/C13-14 isoparaffin/laureth alcohol; 0.2-0.6 part by weight of polydimethylsiloxane/dimethiconol; 0.02-0.08 parts by weight of licoflavone; 1-2 parts by weight of butanediol; 1-4 parts by weight of euglena gracilis polysaccharide/hydrolyzed collagen; the balance being water.
2. The functionally shaped eye cream of claim 1, wherein the eye cream comprises 3 parts by weight of hippophae rhamnoides powder; 50 parts by weight of melissa leaf extract, 2.2 parts by weight of cetearyl alcohol; 3.5 parts by weight of squalane; aloe gel powder 0.11 weight portions; 10 parts of shea butter; 3 parts by weight of hydrogenated jojoba oil; 0.2 part by weight of methylparaben; 0.04 part by weight of sodium hyaluronate; 0.14 part by weight of xanthan gum; 4 parts of glycerol; 7 parts of polyethylene glycol; 0.6 part by weight of polyacrylamide/C13-14 isoparaffin/laureth alcohol; 0.6 part by weight of polydimethylsiloxane/dimethiconol; 0.08 part of licoflavone; 2 parts of butanediol; 4 parts by weight of euglena gracilis polysaccharide/hydrolyzed collagen; the balance being water.
3. The functionally shaped eye cream of claim 1, further comprising 1-30 parts of ceramide.
4. The functionally shaped eye cream of claim 1, further comprising 10-44 parts of an antioxidant.
5. The functional shaping eye cream of claim 1, wherein the sodium hyaluronate is capable of being replaced by glycerin or 1, 3-butanediol, 1, 2-pentanediol.
6. The functionally shaped eye cream of claim 4, wherein the antioxidant is oil soluble vitamin E acetate, sodium phytate, or a mixture thereof.
7. Use of the eye cream according to any one of claims 1 to 6 for the preparation of a cosmetic.
8. Use according to claim 7, the cosmetic being an eye cream.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010686364.5A CN111973470A (en) | 2020-07-16 | 2020-07-16 | Functional shaping eye cream |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010686364.5A CN111973470A (en) | 2020-07-16 | 2020-07-16 | Functional shaping eye cream |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111973470A true CN111973470A (en) | 2020-11-24 |
Family
ID=73438297
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010686364.5A Pending CN111973470A (en) | 2020-07-16 | 2020-07-16 | Functional shaping eye cream |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111973470A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101301297A (en) * | 2007-05-09 | 2008-11-12 | 杏辉天力（杭州）药业有限公司 | Skin photoaging prophylactic agent |
| CN105943448A (en) * | 2016-06-17 | 2016-09-21 | 广州丹奇日用化工厂有限公司 | Black eye removal instant eyelift cream |
-
2020
- 2020-07-16 CN CN202010686364.5A patent/CN111973470A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101301297A (en) * | 2007-05-09 | 2008-11-12 | 杏辉天力（杭州）药业有限公司 | Skin photoaging prophylactic agent |
| CN105943448A (en) * | 2016-06-17 | 2016-09-21 | 广州丹奇日用化工厂有限公司 | Black eye removal instant eyelift cream |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108113914B (en) | Essence cream without essence and preservative and preparation method thereof | |
| CN112402310A (en) | Vitreous chromogen polypeptide anti-wrinkle eye cream and preparation method thereof | |
| CN111228196B (en) | Composition based on wheat germ extracting solution, soothing infant cream and preparation method thereof | |
| US11285093B2 (en) | Cosmetic uses of swertiamarin | |
| KR101490762B1 (en) | Cosmetic composition comprising the polysaccharide of Hibiscus esculentus as active ingredient | |
| US20130310540A1 (en) | Extract of aquatic animal cartilage | |
| KR20120012904A (en) | Cosmetic compositions for improving breast augmentation or skin elasticity | |
| CN111265457A (en) | Whitening and freckle removing essence composition and preparation method thereof | |
| KR20170093694A (en) | Collagen hydrolysate having high concentration of collagen tripeptide and uses thereof | |
| CN112656709A (en) | Skin care compositions and uses thereof | |
| KR20160123732A (en) | Cosmetic composition comprising the extract of cynara scolymus and brassica oleracea var. botrytis as active ingredient | |
| CN106580732A (en) | Emulsion and preparation method thereof | |
| CN112773761B (en) | Cosmetic composition, essence and preparation method thereof | |
| CN113143820A (en) | Anti-aging composition and preparation method thereof | |
| CN111973470A (en) | Functional shaping eye cream | |
| CN116035982A (en) | Marine biological activity repair cream | |
| CN114748399A (en) | Plant anti-wrinkle cosmetic cream and preparation method thereof | |
| CN115414289A (en) | Cordyceps flower cosmetics and preparation method thereof | |
| US7306810B1 (en) | Skin cream | |
| CN113876671A (en) | Anti-aging composition containing rape bud extract and preparation method thereof | |
| KR101154772B1 (en) | Cosmetic composition containing the zizyphus jujuba fruit extract and walnut extract for moisturizing effect on the skin | |
| CN114288201A (en) | Composition for removing under-eye puffiness and fading black eye circles and preparation method and application thereof | |
| CN111297789A (en) | Antiallergic cosmetic composition for pregnant and lying-in women and preparation method and application thereof | |
| CN113069377A (en) | Anti-aging face cream and preparation method thereof | |
| CN112641685A (en) | Moisturizing and circulation promoting essence and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201124 |
|
| RJ01 | Rejection of invention patent application after publication |